The global proton pump inhibitors market is estimated to grow at a CAGR of around 6% during the forecast period. Proton Pump Inhibitors (PPI) is the group of drugs that reduces the risk of gastric acid such as secretion, ulcers and symptoms of gastroesophageal reflux disease in the stomach. Gastroesophageal reflux disease also is known as GERD, is a chronic disease causing problem in the stomach. Additionally, an increase in GERD is due to factors such as tobacco use, obesity and other related problems, this leads to an increase in demand for PPI.

Request a Free Sample of our Global Proton Pump Inhibitors (PPI) Market: https://www.omrglobal.com/request-sample/proton-pump-inhibitors-ppi-market

Furthermore, the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma have a higher risk of developing GERD. In this treatment, the medicines are prescribed orally, in the form of tablets and capsules. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand for novel delivery system accelerating the proton pump inhibitors market growth.

Due to large inclination towards over the counter (OTC) drugs, the market share and growth rate is expected to increase. OTC drugs are the medicines sold directly to consumers without any prescription from healthcare professionals. However, several side effects such as headache, dry mouth, nausea, allergy, diarrhea, kidney-related problems and others related to the treatment hamper the market growth. Apart from this, the diversified market share increases the understanding of various bends that leads to an increase in customer acceptance of esomeprazole drugs is one of the opportunity factors for the PPI market. Apart from this, lack of reach in isolated or remote areas and an increase in consumption of generic drugs can hamper the market growth. However, an increase in demand for novel drugs and introducing new products in the market grab the opportunity factor to increase market growth.

A full Report of Global Proton Pump Inhibitors (PPI) Market is Available at: https://www.omrglobal.com/industry-reports/proton-pump-inhibitors-ppi-market

Global Proton Pump Inhibitors Market Segmentation

By Type

• Esomeprazole
• Omeprazole
• Dexlansoprazole
• Pantoprazole
• Rabeprazole
• Lansoprazole
• Other

By Administration

• Over the Counter
• Prescription

Regional Analysis

• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• Alkem Laboratories, Ltd.
• AstraZeneca PLC
• Aurobindo Pharma, Ltd.
• Bayer AG
• Cadila Healthcare, Ltd.
• Chongqing LUMMY Pharmaceutical Co., Ltd.
• Eisai Co., Ltd.
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals, Inc.
• Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
• Lannett Company, Inc.
• Novartis AG
• Pfizer, Inc.
• Procter & Gamble Co.
• Sanofi S.A.
• Sun Pharmaceutical Industries, Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceuticals Industries, Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/proton-pump-inhibitors-ppi-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404